 Connection
Maryann Degroote to Mycobacterium
This is a "connection" page, showing publications Maryann Degroote has written about Mycobacterium.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.293 |
|
|
|
-
Graham J, Wong CE, Day J, McFaddin E, Ochsner U, Hoang T, Young CL, Ribble W, DeGroote MA, Jarvis T, Sun X. Discovery of benzothiazole amides as potent antimycobacterial agents. Bioorg Med Chem Lett. 2018 10 15; 28(19):3177-3181.
Score: 0.141
-
Davidson RM, DeGroote MA, Marola JL, Buss S, Jones V, McNeil MR, Freifeld AG, Elaine Epperson L, Hasan NA, Jackson M, Iwen PC, Salfinger M, Strong M. Mycobacterium talmoniae sp. nov., a slowly growing mycobacterium isolated from human respiratory samples. Int J Syst Evol Microbiol. 2017 Aug; 67(8):2640-2645.
Score: 0.131
-
Renna M, Schaffner C, Brown K, Shang S, Tamayo MH, Hegyi K, Grimsey NJ, Cusens D, Coulter S, Cooper J, Bowden AR, Newton SM, Kampmann B, Helm J, Jones A, Haworth CS, Basaraba RJ, DeGroote MA, Ordway DJ, Rubinsztein DC, Floto RA. Azithromycin blocks autophagy and may predispose cystic fibrosis patients to mycobacterial infection. J Clin Invest. 2011 Sep; 121(9):3554-63.
Score: 0.022
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|